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ABSTRACT 
The Epidermal Growth Factor Receptor (ErbB1-4) family of tyrosine kinases has been 
associated with many cancer types. Members of the human LIG family, transmembrane 
proteins containing leucine-rich repeats and immunoglobulin domains, have been 
proposed to interact with ErbB1-4. Using the documented Drosophila LIG, Kekkon 1, 
and EGFR interaction, an extracellular interaction assay, ELEXIS, was developed to 
screen for novel human LIG/ErbB1-4 interactions. Any human LIGs interacting with 
ErbB1-4 could have the potential to be used as a cancer therapeutic.    
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INTRODUCTION 
The nervous system consists of billions of neurons connected into circuits that 
allow the integration and propagation of neural activity. To develop neural circuits in the 
body, axons of nerves extend to innervate a target cell. Specifically, in the peripheral 
nervous system, nerve axons are extended from another neuron in the spinal cord to 
innervate muscle or skin cells. This process of growth and branching requires signaling 
peptides and their receptors for coordination. Researchers have found a family of 
signaling proteins, known as LIGs, which appear to interact with certain tyrosine 
receptor kinases to promote neural growth (Mandai et al. 2009). 
 
Leucine-Rich Repeats and Immunoglobulin-Like Domain Containing Proteins 
 
 Leucine-rich repeats and immunoglobulin-like domain containing proteins, or 
LIGs, are transmembrane proteins that contain both leucine-rich repeats, or LRRs, and 
at least one immunoglobulin-like domain, or Ig-
like domain. LRRs and Ig domains are two of 
the most commonly identified sequence 
structures in the metazoan proteome; however, 
relatively few proteins contain both. Typically, 
molecules containing both LRRs and Ig 
domains are involved in protein-protein 
interactions (MacLaren et al. 2004). Figure 1 
shows the general structure of a LIG protein 
with its LRRs and Ig-like domains.  
  
Figure 1. General structure of a leucine-rich 
repeats and immunoglobulin-like domain 
containing protein. The red loop contains the 
LRRs and the white loops contains the Ig domain. 
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One of the best known internal repeating motifs in proteins are leucine rich 
repeats. LRRs are structural motifs that span 20 to 30 amino acids in length, most of 
which are leucine. The N-terminus contains a conserved 11 amino acid residues that 
has the sequence LxxLxLxxNxL, where x is any amino acid, L is leucine, and N is 
asparagine (de Wit et al. 2011). This forms a β-strand and a loop, which connects to the 
C-terminus (Kajava 1998). These repeats come together in tandem to form a LRR 
domain. The domain takes the shape of a solenoid where the β-strands, as β-sheets, 
form the inner concave site and the overall horseshoe shape of the solenoid. The outer 
surface of the solenoid is formed by a variety of structures, including α-helices, 
polyproline II helices, and β-strands (Bella et al. 2008).  
Although one structure of a typical LRR has been described here, many different 
LRRs structures exist in nature. The structural diversity of LRRs allow proteins to have 
diverse functions and to be found in all types of life forms (Bella et al. 2008). The 
solenoid shape has been found to be involved in protein-protein interactions; the 
concave side of the solenoid is found to be the ligand binding site. LRRs are found to be 
involved in the connectivity of neural circuits, hormone-receptor interactions, cell 
adhesion, and cell signaling (de Wit et al. 2011).  
Ig-like domains consist of 80 amino acids that form two antiparallel β-sheets 
linked by β-turns or loops. These turns and loops are held together by disulfide bridges. 
Similar to the immunoglobulin domains in antibodies, Ig-like domains can contain 
variable, or V, regions or constant, or C, regions. However, unlike Ig-domains in 
antibodies, Ig-like domains can contain a V region, C region, or a combination of the two 
(Brümmendorf and Rathjen 1994; Williams and Barclay 1988).  
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Like LRRs, Ig-like domains also play a role in protein-protein interactions and are 
found in a variety of different structures. For example, the Ig-like domain-containing 
proteins in T-cells and antibodies are involved in antigen recognition while LIG proteins 
have been found to be involved in cell-cell adhesion. Proteins with Ig-like domains are 
also involved in ligand-receptor interactions in development, differentiation, activation, 
and regulation (Brümmendorf and Rathjen 1994). 
The LIG proteins can be divided into families that are involved in different 
signaling processes. One certain family of LIGs, known as the LINGOs, has been found 
to play a role in regulation of the differentiation and myelination of oligodendrocytes (Mi 
et al. 2008). Four proteins exist in the LINGO family: LINGO-1, LINGO-2, LINGO-3, and 
LINGO-4, but emphasis will be placed on the first three LINGOs. LINGO-1 contains 11 
LRRs and 1 Ig-like domain. Chen et al 2015 found that LINGO-1-RNA interference-
treated neural stem cells facilitates functional recovery after spinal cord injury and 
represents a 
promising potential 
strategy for the repair 
of spinal cord injury 
(Chen et al. 2015). 
LINGO-2, comprised 
of 12 LRRs and 1 Ig-
like domain, is also 
found to play roles in 
the central nervous 
 
Figure 2. Structure of the LINGO family of LIG proteins. 
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system; LINGO-2 was found to play a role in diseases of the nervous system including 
Parkinson's disease. LINGO-3, comprised of 11 LRRs and 1 Ig-like domain, is still under 
investigation with its specific function being currently unknown (Homma et al. 2009). 
Figure 2 shows the structure of the LINGO family of LIG proteins. 
Another LIG found to potentially play a role in neural development is LINX. LINX, 
also known as immunoglobulin superfamily containing leucine-rich repeat 2 or ISLR2, 
contains 5 LRRs and 1 Ig-like domain. Figure 3 shows the 
structure of LINX. It is found in the central nervous system 
and thought to interact with RTKs (Mandai et al. 2009).  
Although LIGs have multiple functions, the two that 
will be focused on are their role in the nervous system and 
their interactions with receptor tyrosine kinases, or RTKs. 
As stated previously, LIGs are known to promote neural 
growth by signaling for the growth of neural cells during 
development. They have also been found to aid in synaptic 
plasticity in developed nervous systems.  
 
Epidermal Growth Factor Receptors 
The Epidermal Growth Factor Receptors, or EGFR/ErbB, are a family of Tyrosine 
Kinase Receptors, or RTKs. There are four ErbB proteins identified in humans -  
EGFR/ErbB-1/HER1, ErbB-2/HER2, ErbB-3/HER3, and ErbB-4/HER4. The ErbB 
receptors are specifically known for the role they play in cancer, especially breast 
cancer, and neural and early embryonic development (Normanno et al. 2006). These 
 
Figure 3. Structure of the LIG 
protein LINX. 
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cell surface receptors are made of an intracellular 
domain, a short hydrophobic transmembrane 
domain, and an extracellular ligand-binding 
domain (Blume-Jensen and Hunter, 2001; 
Scaltriti and Baselga, 2006; Normanno et al, 
2006; Figure 4). Within the extracellular region, 
the ErbB receptors contain four subdomains, 
named domains I-IV. Domains I and III are 
important for ligand binding, which is discussed 
further in this chapter, and are composed of beta-
helices and leucine-rich sequences. Domains II and IV are cysteine rich. The 
extracellular region is connected to the intracellular region by the transmembrane 
domain. The intracellular domain, which is highly conserved, is composed of a tyrosine 
kinase domain that is surrounded by a juxtamembrane region and a carboxyl (C-) 
terminal tail (Normanno et al. 2006). Figure 4 shows the structure of an ErbB receptor. 
The structure of these receptors allows signals to be transmitted across the plasma 
membrane to activate gene expression and induce cellular responses (Yarden, 2001). 
ErbBs are involved in cell signaling that helps regulate functions such as proliferation, 
differentiation, migration, and apoptosis by relaying information to the nucleus 
(Schlessinger and Lemon, 2006).  
The activation of ErbBs is ligand dependent. Ligands are ErbB-specific growth 
factors that are produced by cells either by the same cell with the receptor, known as 
autocrine secretion, or by surrounding cells, known as paracrine secretion.   Each ligand 
 
Figure 4. Structure of ErbB receptor.  
 
 10 
can be divided into one of three groups: ligands that specifically bind to EGFR including 
epidermal growth factor (EGF), transforming growth factor alpha (TGF-alpha), and 
amphiregulin (AR); ligands that bind to both ErbB-3 and EGFR including betacellulin 
(BTC), heparin-binding EGF-like growth factor (HB-EGF), and epiregulin (EPR); and 
ligands that bind to both ErbB-3 and ErbB-4 including neuregulins (NRGs). None of the 
ligands bind to the extracellular domain of 
ErbB-2; domains I and III are structurally 
similar and prevent ligand binding. Because 
of this, ErbB-2 is the preferred dimerization 
pair for the other ErbB receptors. Although it 
has ligand binding, ErbB-3 lacks tyrosine 
kinase activity in its intracellular domain 
(Normanno et al. 2006). Figure 5 shows the 
structure for each ErbB receptor.  
When these ligands bind to the 
extracellular domain, the ErbB receptors 
induce the formation of dimers that activate the intrinsic tyrosine kinase domain. This 
receptor activation causes phosphorylation of tyrosine residues that serve as docking 
sites for proteins. The docking of proteins leads to an activation of intracellular signaling 
pathways and eventually a cell response (Normanno et al. 2006). Figure 6 shows ErbB 
receptor activation.   
Studies on the crystal structure of the ErbB family receptors show that they 
distinguish themselves from other RTKs with respect to their dimerization and activation 
 
 
 
Figure 5. Family of Epidermal Growth Factor 
Receptors ErbB-2, pictured on the top right, 
has no known ligand associated, which is 
indicated by the blue extracellular domain. 
ErbB-3, pictured on the bottom left, although 
it has ligand activity, does not have tyrosine 
kinase activity, indicated by a darkened 
intracellular domain. 
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process. ErbB receptor dimerization is promoted by a beta hairpin known as a 
dimerization loop that protrudes from subdomain II and mediates interaction with 
another ErbB receptor, forming 1:1 receptor/ligand complexes (Normanno et al. 2006). 
Only subdomains II and IV are involved with 
receptor dimerization; subdomains I and III 
are involved with ligand binding. Without a 
bound ligand the receptors stay as monomers 
with the dimerization loop hidden (Lemmon et 
al, 2014). Ligand binding to domains I and III 
brings the two subdomains together, causing 
a conformational change in subdomains II and 
IV that exposes the dimerization loop. This 
change also causes a self-association 
between ErbBs (Normanno et al. 2006; Figure 
6). 
 
 
 
Figure 6. ErbB receptors mechanism of 
action in tumor cells. ErbB receptors are 
activated through the binding of specific 
ligands that are produced by either the 
mutated cells or by surrounding cells. 
Binding of ligands to the extracellular 
domain of ErbB receptors results in 
receptor dimerization, tyrosine kinase 
activation and phosphorylation. The 
activated ErbB receptors interact with 
different signaling molecules to transmit the 
signal in the cell.  
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MATERIALS AND METHODS 
 
Generating LIG Constructs for Bait Proteins 
 AP-tagged LIG constructs were designed in silico using GCK software for 
LINGO1, LINGO2, LINGO3, and LINX and then constructed using standard molecular 
techniques and the Gateway cloning system. Using 5’ and 3’ primers, the pUAST-AP 
destination vector was generated by amplifying the protein tag from Dscam 7.27.25 
DNA samples obtained from the Zipursky lab (Wojtowicz, et al. 2007) by previous 
members of the Duffy lab. sLIG constructs were then subcloned using a BP GatewayTM 
(Invitrogen) reaction to form an entry clone, or pENTR.  These pENTR constructs were 
sequenced confirmed by Eton BioScience and analyzed by the Sequencher software.  
Each sLIG pENTR construct was then subcloned into the pUAST-AP destination vector 
through a LR GatewayTM (Invitrogen) reaction to produce an expression clone with the 
gene of interest and the AP tag. 
 
Transfection of LIG Expression Clones 
 S3 Drosophila cells were thawed and maintained as described by Cherbas, et al 
(Cherbas, 1998). To transfect cells with the DNA constructs, cells were first counted to 
3.125 x 106 cells/ml and 1.6 ml of cells were seeded in 6-well cell culture plates.  The 
seeded cells were incubated for 24 hours under normal growth conditions of 25°C 
without CO2 to obtain 100% confluence. The cells were then co-transfected with both 
the constitutative Arm-GAL4 driver and the respective LIG pUAST responder constructs 
(LINGO1-AP, LINGO2-AP, LINGO3-AP, and LINX-AP) following the protocol described 
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by Wojtowicz et al (Wojtowicz, et al. 2007).  Figure 7 shows the procedure used to 
transfect cells with AP-tagged LIG constructs. 
After incubating for 1 week, the growth media was collected and gently centrifuged to 
pellet any suspended cells.  The supernatant was collected, filtered with a 0.22 µm PES 
filter, vortexed, and aliquoted into eppendorf tubes.  Each protein sample was then 
stored at 4° C.  
 
Bait Quantification 
 Each AP bait sample was quantified by hPLAP enzymatic activity in a kinetic 
assay against an hPLAP enzymatic standard curve.  To obtain the hPLAP standard 
curve, a dilution series of 100 U/L, 75 U/L, 50 U/L, 25 U/L, 10 U/L in of hPLAP in cell 
culture supernatant was generated.  The activity of each AP bait sample was assessed 
against the standard curve by creating a dilution series of 100 µl, 75 µl, 50 µl, 20 µl, and 
10 µl of each AP bait sample in cell culture supernatant. The activity of each sample at 
each concentration against the activity of cell culture supernatant was assayed by 
adding an equal volume of PNPP (Pierce) substrate to both the hPLAP standards and 
AP-tagged protein samples and tracked every minute over a 20 minute time frame at 
 
 
 
Figure 7. GAL4/UAS system used in co-transfection with AP-tagged LIG constructs for protein 
expression. 
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405 nm using a Victor3 plate reader and Wallac software.  The reaction was then kept 
in the dark and incubated at room temperature until 75 minutes when the plate was 
measured at 405 nm using a SpectraMax plate reader and Softmax Pro software.  The 
reaction was stopped at 86 minutes with 50 µl of 2 N Sodium Hydroxide (NaOH) and 
measured at 405 nm using a SpectraMax plate reader and Softmax Pro software.  The 
velocities of each hPLAP and AP bait sample concentration over 10 minutes were 
converted into a standard curve assessing hPLAP velocity vs. hPLAP concentration 
(U/L) that was used to quantify the hPLAP concentration in each AP bait sample. These 
velocities were used to quantify and normalize the AP-tagged protein samples against 
the hPLAP standard curve. The amount of each AP bait sample to use in each protein 
interaction was normalized to 502 uU for each interaction. 
 
Protein Interactions 
 To determine if AP-tagged LIGs interact with Fc-tagged ErbB family of receptors, 
an ELISA based screening assay was 
developed (Wojtowicz, et al. 2007). 
This enzyme linked extracellular 
interaction screen, or ELEXIS, is 
diagrammed in (Figure 8). 
Each interaction well was 
incubated with a mixture of 3 µg/mL 
Ms-anti-AP (8B6.18 Thermo) in 1x PBS (10 mM Na2HPO4, 2 mM KH2PO4, 2.7 mM KCl, 
and 137 mM NaCl) overnight at 4° C on a rocking platform.  Wells were washed 4x1min 
 
Figure 8. Structure of an ELEXIS assay. 
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with 300 µl of wash buffer PBST (1x PBS and 0.05% Tween20) at room temperature on 
a rocking platform.  400 µl of Casein block solution (1% Casein in 1x PBS) was added 
to each well and incubated for 1.5 hours at room temperature on a rocking platform.  
Each interaction solution was generated during the blocking incubation and contained 
100 ng of each Fc-tagged interacting prey sample, 520 uU of the AP bait sample, a final 
concentration of 2 µg/mL of the HRP conjugated Ms-anti-Fc detection antibody, and 
supernatant to a total volume of 50 µl (to interact the Dscam proteins (Dscam7 and 
Dscam1) we used 67.67 -15.6 ng of Fc and 11 ng of AP).  The block solution was 
removed and the interaction mix was added into each well and incubated for 4 hours at 
room temperature on a rocking platform protected from light.  Wells were washed 4x1 
min with 300 µl of PBST at room temperature on a rocking platform protected from light.  
For detecting the presence of an interaction 100 µl of 1-Step TMB Ultra HRP Substrate 
(Pierce) was added to each well and tracked at 590 nm for 1 hour at room temperature 
using a Victor3 plate reader and Wallac software.  The reactions in each well were 
stopped with 100 µl of 1 M Phosphoric Acid (H3PO4) stop solution and the endpoint 
absorbance was detected at 450 nm.  Each protein interaction was compared to the 
highly confident and previously published interaction between sdEGFR-Fc and sKek1-
AP or the homodimerization interaction of sDscam7 as a benchmark for a true positive 
interaction.  Negative interactions were determined by comparing each protein 
interaction with the non-functional interaction between sdEGFR-Fc and sKek2-AP or the 
heterodimerization interaction between sDscam7-AP and sDscam1-Fc.  False positive 
interactions were determined by comparing the interaction to both AP-tagged bait with 
supernatant and Fc-tagged prey with supernatant. 
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RESULTS 
 
Generating AP-tagged LIG Constructs 
 To determine the possible interaction between LIG proteins and the ErbB family 
of receptors, prey and bait constructs needed to be generated for both sets of 
molecules. Prior work in the lab had generated constructs for the ErbB family. However, 
similar constructs for the LIG proteins were incomplete. Because the focus was on 
creating the bait proteins, DNA constructs for AP-tagged LIG proteins were generated. 
The pENTR vector for LINGO1, LINGO2, LINGO3, and LINX were generated by 
previous members of the Duffy lab and sequenced to ensure that the constructs were 
correct. The pENTR clones for LINGO1, LINGO2, LINGO3, and LINX were used to 
perform LR reactions with AP-containing pUAST vectors to obtain the expression 
constructs for the AP-tagged versions of LINGO1, LINGO2, LINGO3, and LINX. All 
constructs were verified by restriction digestion and sequencing.  In addition, the Fc 
constructs for LINGO3 and LINX were generated and confirmed, but were not used 
here. 
 
Verifying and Quantifying Protein 
Expression 
 After co-transfection with Arm-
GAL4 into S3 Drosophila cells, the LIG 
proteins were verified and quantified 
using an ELISA-based AP activity 
assay. This assay used PNPP substrate with the AP-tagged proteins and an AP-
conjugated antibody as a standard to assess the alkaline phosphatase activity of the 
 
Figure 9. Picture of a typical AP activity assay. 
The first row contains the hPLAP standard curve, 
the middle rows contain the AP-tagged protein 
dilution series for 3 different protein samples, and 
the bottom row contains supernatant harvested 
from cells not transfected with AP-tagged LIG 
constructs. 
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protein. The absorbance signals of the antibody dilutions at 405nm were plotted as a 
standard curve of PNP product conversion, using absorbance, as a function of AP 
activity levels. Figure 9 shows the color of a typical plate after the activity assay; Figure 
10 shows the graph of the hPLAP standard curve. 
The absorbance 
signals of each 
AP-tagged protein 
dilutions were 
plotted as a linear 
regression of 
absorbance as a 
function of time. 
Figures 11 and 12 
show the activity 
plots for sLINGO3 and sLINX activity respectively. To determine the amount of protein 
present in the harvested supernatant, the readings for the undiluted sample were used 
for calculations. The protein concentration for LINGO3-AP was 18.3 pg/uL while the 
protein concentration for LINX-AP was 880 pg/uL.  Based on these activity tests, both 
LINGO3-AP and LINX-AP appear to be produced and stable. 
In contrast, the signals for LINGO1-AP and LINGO2-AP were too low to determine if 
protein had been expressed and therefore quantified. Based on this, it is not clear 
whether or not those proteins were expressed and therefore whether or not we would 
be capable of expressing them. 
 
Figure 10. Graph of hPLAP standard curve used to determine concentration of 
AP-tagged LIGs in harvested supernatant. 
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Figure 11. Activity Plot for AP activity test using harvested 
sLINGO3. 
 
 
 
 
 
 
 
Figure 12. Activity Plot for AP activity test using harvested 
sLINX. 
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Testing Interactions 
The obtained and quantified secreted versions of LINGO3-AP and LINX-AP were 
tested for interaction with the ErbB family of receptors. Kek1/DER and Dscam7/Dscam7 
interactions were used for positive controls and Kek2/DER and Dscam7/Dscam1 
interactions were used for negative controls. All LIG proteins and ErbB receptor proteins 
were run against supernatant as a baseline reading. The secreted versions of Fc-
tagged ErbB1, ErbB2, ErbB4, DER, Dscam7, and Dscam1 and the secreted versions of 
AP-tagged Dscam7, Kek1, and Kek2 were 
provided by Alex Putnam of the Duffy lab. 
 In the assay, LIG/ErbB interactions are 
displayed using absorbance readings at 590 
nm from the conversion of TMB substrate and 
at 490 nm once the reaction is stopped. If the 
proteins are interacting in the well, the well will 
turn blue and then yellow once the reaction is 
stopped. If little to no proteins are interacting 
in the well, little to no color is observed. Figure 
13 shows the color differences for the wells in a typical ELEXIS plate. 
 Figure 14 shows the fold difference for absorbance readings compared to their 
readings above background for the most recent ELEXIS. Compared to the fold 
differences for the Dscam7 dimerization interaction and the Dscam7/Dscam1 
heterodimerization, the fold difference for the LINGO/ErbB and LINX/ErbB interactions 
over background was 1.  Based on these preliminary results, in the ELEXIS assay 
 
Figure 13. Picture of a typical ELEXIS 
assay with labeled positive interaction 
control and antibody activity test. 
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LINGO3 does not appear to interact with the ErbB receptors, while LINX appeared to 
interact with ErbB2 in some replicates, but not others.    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 14. sLINGO3 and sLINX fold differences over background compared to the positive and negative 
controls.  
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DISCUSSION 
 
 Prior work had suggested that members of the LIG family were capable of 
interacting with members of the ErbB family.  To further investigate this, the ELEXIS 
assay was used to test specific LIG/ErbB interactions. To do this, pUAST clones of 
secreted AP-tagged LIG proteins were produced. Out of the 10 constructs that were 
attempted, only 4 of the 36 AP-tagged LIG protein constructs were successfully 
produced: LINGO1-AP, LINGO2-AP, LINGO3-AP, and LINX-AP. These constructs were 
then used in transfection of Drosophila cells to produce secreted versions of these 
proteins. It was observed that the pUAST-AP expression constructs that had lower 
concentration readings, LINGO1-AP and LINGO2-AP, were unable to produce 
quantifiable amounts of protein, indicating these constructs will likely need to be re-
prepped and transfected. In contrast, quantifiable secreted versions of LINGO3-AP and 
LINX-AP were obtained. 
 Once the proteins were obtained and quantified, LINGO3-AP and LINX-AP were 
run against ErbB1-4-Fc in an ELEXIS assay. To ensure that the assay was functional, 
positive and negative controls were successfully run. The positive controls gave high 
signal and the negative controls gave little to no signal, which indicates that the assay 
was functional. Preliminary data indicates minimal signal was detected for the wells 
containing sLINGO3 and sLINX with sErbB1, 2, and 4 and DER. Based on these 
results, we were unable to detect an interaction between sLINGO3 and sLINX with 
either the Drosophila or Human EGF Receptors. 
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One possibility for the lack of interaction between sLINGO3-AP and sLINX-AP and 
sErbB1-4-Fc is that the proteins are nonfunctional (i.e. misfolded) and therefore unable 
to interact with any proteins. Further work must be done to confirm the functionality of 
the LIGs and the ErbBs. One possible approach to this would be to perform LIG-LIG 
and ErbB-ErbB dimerization interactions. To do this, the Fc-tagged LIG proteins also 
constructed above would be useful. If an LIG-LIG or ErbB-ErbB interaction is detected, 
it would indicate that the proteins dimerize confirming a degree of functional activity. 
Confirming functionality for a given LIG or ErbB in this way data would then provide a 
stronger argument for the relevance of any negative interaction. Further investigation 
into the possible interactions of other subfamilies of with ErbB1-4 should be conducted 
as well.  
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APPENDIX A: RAW ELEXIS DATA 
 
 
Table 1. Raw data of ELEXIS assay with sLINGO3 and sLINX as bait and DER and ErbB1 
as prey. 
 
 
Table 2. Raw data of ELEXIS assay with sLINGO3 and sLINX as bait and ErbB1-4 as 
prey. 
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Table 3. Raw data of ELEXIS assay with sLINX as bait and DER and ErbB1 as prey. 
 
 
